News

Mr Yockstick has broad management experience in executive and leadership positions across a wide range of commercial, operational, and quality functions, as well as being a leader and

Most recently, Mr Fust was executive vice president and CFO at Jazz Pharmaceuticals, which he joined in 2003. From 2002 until 2003, he was CFO at Perlegen Sciences.

Under the first tranche of the agreement, the company issued 2.6 million common shares at a price of $1.25 per common share. The common shares issued pursuant to

The proposal was communicated in a letter from Jeff Himawan, the chairman of MediciNova, to Zola Horovitz, the chairman of Avigen. The letter delivered to Dr Horovitz further

As part of its effort to restructure and consolidate operations, Neurogen is divesting certain non-core assets. Neurogen’s C5a patent estate and related assets were generated as part of

Dr Reddy’s will also market a generic version of the Clarinex 5mg tablet six months after the launch of the first generic version of that product. The agreements

The first step in this reorganization is the establishment of Covidien’s tax residency in Ireland in December 2008. Covidien shareholders then will be asked to vote in favor

The combined company will have a significant presence in over 60 countries and generated approximately $13.6 billion in revenues on a pro-forma basis for the 12 months ended

Dr Shebuski, a cardiovascular pharmacologist, has broad experience in cardiovascular drug development with over 25 years in the pharmaceutical industry. He will be responsible for the pre-clinical and